Compositions for radiotherapy and uses thereof

US2016331853A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016331853-A1
Application numberUS-201515112589-A
CountryUS
Kind codeA1
Filing dateJan 21, 2015
Priority dateJan 21, 2014
Publication dateNov 17, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are compositions and methods for treatment of a disease, disorder, or condition, such as a proliferative disease, disorder, or condition. One aspect provides a kit including a first composition including a bare ligand or a ligand coupled to a molecule or substrate; and a second composition including a receptor coupled to a radioisotope. Another aspect provides methods for treating a disease, disorder, or condition.

First claim

Opening claim text (preview).

1 . A kit for treatment of a proliferative disease, disorder, or condition comprising: a first composition comprising (i) a ligand coupled to a molecule or a substrate or (ii) a ligand; and a second composition comprising a receptor coupled to a radioisotope; wherein the ligand comprises specific or non-specific affinity for the receptor. 2 . The kit of claim 1 , wherein the ligand comprises a streptavidin, streptavidin variant, avidin, avidin variant, or molecularly imprinted polymer. 3 . The kit of claim 1 , wherein the ligand is a PEGylated ligand. 4 . The kit of claim 1 , wherein first composition consists essentially of a ligand and the ligand has specific or non-specific affinity for a target tissue associated with the proliferative disease, disorder, or condition. 5 . The kit of claim 1 , wherein the receptor comprises a biotin. 6 . The kit of claim 1 , wherein the radioisotope comprises lutetium-177, yttrium-90, iodine-131, phosphorus-32, boron-10, radium-223, bismuth-213, lead-212, holmium-166, dysprosium-165, erbium-169, iodine-125, iridium-192, rhenium-186, rhenium-188, samarium-153, strontium-89, a cesium radioisotope, a gold radioisotope, or a ruthenium radioisotope. 7 . The kit of claim 1 , wherein the molecule or substrate comprises natural or artificial material. 8 . The kit of claim 1 , wherein the molecule or substrate comprises: (i) a silicate, talc, fibrin, fibrin glue, gelatin, or gelfoam, or combinations thereof; (ii) gold, tantalum, iridium, platinum, nitinol, stainless steel, platinum, titanium, tantalum, nickel-titanium, cobalt-chromium, magnesium, ferromagnetic, nonferromagnetic, alloys thereof, fiber, cellulose, a biodegradable polymer, or a non-biodegradable polymer, or a combinations thereof; (iii) a non-biodegradable polymer selected from the group consisting of polyetheretherketone (PEEK), PEEK derivatives, polyethyleneteraphthalate, polyetherimide, polymide, polyethylene, polyvinylfluoride, polyphenylene, polytetrafluroethylene-co-hexafluoropropylene, polymethylmethacrylate, polyetherketone, poly (ethylene-co-hexafluoropropylene), polyphenylenesulfide, polycarbonate, poly (vinylidene fluoride-co-hexafluoropropylene), poly (tetrafluoroethylene-co-ethylene), polypropylene, or polyvinylidene fluoride, or combinations thereof; (iv) a biodegradable material selected from the group consisting of polycaprolactone, poly (D,-lactide), polyhydroxyvalerate, polyanhydrides, polyhydroxybutyrate, polyorthoesters, polyglycolide, poly (L-lactide), copolymers of lactide and glycolide, polyphosphazenes, or polytrimethylenecarbonate, or combinations thereof; (v) a drug-delivering vascular stent, self-expanding stent, balloon-expanded stent, vascular device, graft, catheter, valve, artificial heart, heart assist device, implantable defibrillator, defibrillator lead, blood oxygenator device, blood oxygenator tubing, blood oxygenator membrane, surgical device, suture, staple, anastomosis device, vertebral disk, bone pin, suture anchor, hemostatic barrier, clamp, screw, plate, clip, vascular implant, tissue adhesive or sealant, tissue scaffold, membrane, cell culture device, chromatographic support material, biosensor, shunt for hydrocephalus, wound management device, endoscopic device, infection control device, orthopedic device, joint orthopedic implant, orthopedic fracture repair device, dental device, dental implant, dental fracture repair device, urological device, penile urological device, sphincter urological device, urethral urological device, bladder urological device, prostrate urological device, vaginal urological device, fallopian urological device, renal urological device, urological catheter, colostomy bag attachment device, ophthalmic device, ocular coil ophthalmic device, glaucoma drain shunt, synthetic prostheses, breast synthetic prostheses, intraocular lens, respiratory device, peripheral device, cardiovascular device, spinal device, neurological device, dental device, gastro-intestinal device, gastro-esophageal device, ear/nose/throat device, ear drainage tube device, renal device, iliac device, cardiac device, aortic devices, aortic graft, aortic stent, dialysis device, dialysis tubing, dialysis membrane, dialysis graft, urinary catheter, antimicrobial surface-coated urinary catheter, intravenous catheter, intravenous catheter treated with antithrombotic agent comprising heparin, hirudin, or coumadin, tissue graft, small diameter tissue graft, tissue scaffold, vascular graft, artificial lung catheter, atrial septal defect closure, electro-stimulation leads for cardiac rhythm management, pacer leads, glucose sensor, long-term glucose sensor, short-term glucose sensor, degradable coronary stent, non-degradable coronary stent, partially degradable coronary stent, blood pressure and stent graft catheter, birth control device, benign prostate implant, prostate cancer implant, bone repair device, bone augmentation device, breast implant, cartilage repair device, dental implant, implanted drug infusion tube, intravitreal drug delivery device, nerve regeneration conduit, oncological implant, electrostimulation lead, pain management implant, spinal repair device, orthopedic repair device, wound dressing, embolic protection filter, abdominal aortic aneurysm graft, heart valve, mechanical heart valve, polymeric heart valve, tissue heart valve, percutaneous, carbon heart valve, sewing cuff heart valve, valve annuloplasty device, mitral valve repair device, vascular intervention device, left ventricle assist device, neuro aneurysm treatment coil, neurological catheter, left atrial appendage filter, hemodialysis device, catheter cuff, anastomotic closure, vascular access catheter, cardiac sensor, uterine bleeding patch, uterine stent or stent-like device, cervix treatment device, urological catheter, urological stent, urological implant, gastro-esophageal stent, aneurysm exclusion device, neuropatch, vena cava filter, urinary dilator, endoscopic surgical tissue extractor, endoscopic drug delivery device, fluid delivery device, atherectomy catheter, atherectomy device, imaging catheter, imaging device, Intravascular Ultrasound imaging catheter or device, Magnetic Resonance Imaging catheter or device, Optical Coherence Tomography imaging catheter or device, thrombis extraction catheter or device, clot extraction catheter or device, thrombectomy device, percutaneous transluminal angioplasty catheter or device, PTCA catheter, stylet, vascular stylet, non-vascular stylet, guiding catheter, drug infusion catheter, esophageal stent, pulmonary stent, bronchial stent, circulatory support system, angiographic catheter, transition sheath, transition dilator, coronary guidewire, hemodialysis catheter, peripheral guidewire, hemodialysis catheter, neurovascular balloon catheter or device, tympanostomy vent tube, cerebro-spinal fluid shunt, defibrillator lead, percutaneous closure device, drainage tube, thoracic cavity suction drainage catheter, electrophysiology catheter or device, stroke therapy catheter or device, abscess drainage catheter, biliary drainage device, dialysis catheter, central venous access catheter, parental feeding catheter or device, implantable vascular access port, blood storage bag, vascular stent, blood tubing, arterial catheter, vascular graft, intraaortic balloon pump, suture, cardiovascular suture, total artificial heart, ventricular assist pump, extracorporeal device, blood oxygenator, blood filter, hemodialysis unit, hemoperfusion unit, plasmapheresis unit, hybrid artificial organ, hybrid artificial pancreas, hybrid artificial liver, hybrid artificial lung, blood vessel emboli filter, distal protection device, distal embolic protection device, or combinations thereof; or (vi) combinations thereof. 9 . A method of treatin

Assignees

Inventors

Classifications

  • the form being a particulate, a powder, an adsorbate, a bead or a sphere · CPC title

  • Peroxidase (1.11.1.7), i.e. horseradish-peroxidase · CPC title

  • Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin · CPC title

  • conjugates with a carrier being an organic compounds · CPC title

  • Pretargeting · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016331853A1 cover?
Provided herein are compositions and methods for treatment of a disease, disorder, or condition, such as a proliferative disease, disorder, or condition. One aspect provides a kit including a first composition including a bare ligand or a ligand coupled to a molecule or substrate; and a second composition including a receptor coupled to a radioisotope. Another aspect provides methods for treati…
Who is the assignee on this patent?
Univ Columbia
What technology area does this patent fall under?
Primary CPC classification A61K51/0495. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).